Senior insider sale
GALECTIN THERAPEUTICS INC — senior position signals high conviction
$526.4K
80.25K shares
What this filing means
LEWIS JOEL plans to sell 80.25K shares of GALECTIN THERAPEUTICS INC valued at approximately $526.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/17/2025ACC: 0001972481-25-000317
80.25K
Shares to sell
$526.4K
Approx. market value
40K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
1/9/2020
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/9/2020 | Option Exercise Cash | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
6.78K
Market value
$41.7K
11/18/2025
—Completed
Units to sell
15.68K
Market value
$94.6K
11/17/2025
—Completed
Units to sell
1.87K
Market value
$11.3K
11/10/2025
—Completed
Units to sell
200.00
Market value
$1.2K
11/5/2025
—Completed
Units to sell
14.42K
Market value
$87.5K
11/4/2025
—Completed
Units to sell
1.30K
Market value
$7.8K
11/3/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
40K
Market value
$282.2K
12/17/2025
Total
Units
80.25K
Value
$526.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 6.78K | $41.7K | — | Completed |
11/17/2025 | 15.68K | $94.6K | — | Completed |
11/10/2025 | 1.87K | $11.3K | — | Completed |
11/5/2025 | 200.00 | $1.2K | — | Completed |
11/4/2025 | 14.42K | $87.5K | — | Completed |
11/3/2025 | 1.30K | $7.8K | — | Completed |
| Planned — Approximate Date | ||||
12/17/2025 | 40K | $282.2K | Nasdaq | Planned |
| Total | 80.25K | $526.4K | ||